DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,070 | +22.4% | 162,699 | +35.5% | 0.18% | +4.7% |
| Q2 2023 | $1,691 | +7.1% | 120,095 | +17.5% | 0.17% | +8.3% |
| Q1 2023 | $1,579 | +41.1% | 102,231 | +49.7% | 0.16% | +12.2% |
| Q4 2022 | $1,119 | -99.6% | 68,289 | +379.3% | 0.14% | +297.1% |
| Q3 2022 | $264,000 | -19.5% | 14,247 | -42.8% | 0.04% | -28.6% |
| Q2 2022 | $328,000 | +89.6% | 24,923 | +33.2% | 0.05% | +113.0% |
| Q1 2022 | $173,000 | +15.3% | 18,713 | +21.6% | 0.02% | +21.1% |
| Q4 2021 | $150,000 | -92.7% | 15,388 | -74.6% | 0.02% | -91.0% |
| Q3 2021 | $2,057,000 | +637.3% | 60,550 | +1138.2% | 0.21% | +356.5% |
| Q4 2020 | $279,000 | -29.0% | 4,890 | -48.8% | 0.05% | -53.5% |
| Q1 2020 | $393,000 | – | 9,548 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |